文献速递临床试验与 GCP基础与转化研究

经皮胫神经刺激治疗经尿道前列腺电切术后导管相关膀胱不适的随机双盲安慰剂对照试验

Transcutaneous tibial nerve stimulation versus sham stimulation for the treatment of catheter-related bladder discomfort in patients undergoing transurethral resection of the prostate: a prospective, randomized, placebo-controlled, double-blind trial.
PubMed 文献 · Trials · 2026-04-28

本研究为前瞻性、随机、双盲、安慰剂对照临床试验,纳入全麻下行经尿道前列腺电切术的患者,按1:1随机分配至经皮胫神经刺激组或假刺激组。主要结局为干预后即刻采用数字评分量表评估的导管相关膀胱不适严重程度,次要结局包括干预后1、2、6小时的严重程度与疼痛评分、镇痛药消耗、患者满意度及术后谵妄发生率。

要点

  • 经皮胫神经刺激是无创神经调控疗法,可能成为导管相关膀胱不适的安全替代治疗。
  • 主要结局为干预后即刻NRS评估的导管相关膀胱不适严重程度。
  • 次要结局涵盖干预后1、2、6小时的不适与疼痛评分、镇痛药消耗及满意度。

核心结论

  • 该试验方案旨在评估经皮胫神经刺激治疗经尿道前列腺电切术后导管相关膀胱不适的治疗潜力,探索其作为当前管理方式无创替代方案的可行性。

研究设计与样本

  • 前瞻性、随机、双盲、安慰剂对照临床试验,纳入全麻下行经尿道前列腺电切术的患者。
  • 参与者按1:1比例随机分配至经皮胫神经刺激组或假刺激组。

关键数值与推荐

  • 主要结局为干预后即刻采用数字评分量表评估的导管相关膀胱不适相关不适严重程度。
  • 次要结局包括干预后1、2、6小时导管相关膀胱不适严重程度与疼痛评分、镇痛药消耗、患者满意度评分及术后谵妄发生情况。
  • 试验注册号:中国临床试验注册中心ChiCTR2400088488,注册日期2024年8月20日。

临床怎么用

  • 经皮胫神经刺激作为无创神经调控疗法,可能为经尿道前列腺电切术后导管相关膀胱不适提供安全有效的替代治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Catheter-related bladder discomfort (CRBD), characterized by urinary urgency, frequency, and suprapubic pain, is a clinically significant complication following transurethral resection of the prostate (TURP). Current CRBD pharmacotherapy faces inherent limitations due to adverse effect profiles. Transcutaneous tibial nerve stimulation (TTNS), a noninvasive neuromodulation therapy with demonstrated efficacy in bladder dysfunction management, shows particular promise as a safe and effective alternative for CRBD treatment. METHODS: This prospective, randomized, double-blind, placebo-controlled clinical trial enrolled patients undergoing TURP under general anesthesia. Participants were randomly allocated in a 1:1 ratio to either active TTNS intervention or sham stimulation. The primary outcome focused on CRBD-related discomfort severity assessed via the Numeric Rating Scale (NRS) immediately post-intervention. Secondary outcomes comprised CRBD severity and pain scores at 1-, 2-, and 6-h post-intervention intervals, analgesic consumption, patient satisfaction ratings, and occurrence of postoperative delirium. DISCUSSION: This protocol evaluates the therapeutic potential of TTNS for CRBD following TURP, exploring its viability as a non-invasive alternative to current CRBD management. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2400088488. Registered on 20th August 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Song Y, Sun X, Mei L, et al. Transcutaneous tibial nerve stimulation versus sham stimulation for the treatment of catheter-related bladder discomfort in patients undergoing transurethral resection of the prostate: a prospective, randomized, placebo-controlled, double-blind trial. Trials. 2026. PMID: 42050700. doi:10.1186/s13063-026-09743-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。